Telomere dysfunction, p53 and tumorigenesis
端粒功能障碍、p53 和肿瘤发生
基本信息
- 批准号:7666826
- 负责人:
- 金额:$ 15.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:A MouseAddressApoptosisApoptoticAtaxia-Telangiectasia-Mutated protein kinaseBindingBiological ProcessCell AgingCell Cycle ArrestCellsCharacteristicsChromosomal StabilityChromosome abnormalityChromosomesComplexCytogenetic AnalysisDNADNA DamageDNA damage checkpointDataDevelopmentDicentric chromosomeEmbryoEnsureFibroblastsFunctional disorderGalactosidaseGenerationsGenome StabilityGenomic InstabilityGenotypeGoalsHandHeterochromatinHumanIn VitroIncidenceInvadedKnockout MiceLengthMaintenanceMalignant - descriptorMalignant NeoplasmsMammalsMediatingMolecularMolecular ConformationMolecular TargetMonitorMusNucleoproteinsOncogenesPathway interactionsPlayProcessProtein ArrayReciprocal TranslocationRegulationRepetitive SequenceResearch Project GrantsRiskRoleSamplingSignal TransductionSingle-Stranded Telomere-Binding ProteinsSmall Interfering RNASpectral KaryotypingStructureSubfamily lentivirinaeSystemTP53 geneTelomere-Binding ProteinsTestingTissuesTumor Suppressor Proteinsbasecancer cellcancer initiationcohortcomparative genomic hybridizationhuman CCR6 proteinin vivomouse modelp53 Signaling Pathwaypreventresearch studyresponsesenescencesensortelomeretumortumor initiationtumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Telomeres, the nucleoprotein structures that cap the ends of eukaryotic chromosomes, are composed of TTAGGG repetitive sequences that terminate in a 3' single-stranded G-rich overhang. Telomeres are bound by a complex array of proteins that help stabilize its formation and serve essential roles in preventing DNA damage checkpoint activation. Recent evidence suggests that telomere dysfunction is associated with increased human cancer incidence. Telomere dysfunction leads to the generation of dicentric chromosomes that initiate the breakage-fusion-bridge (BFB) cycle to elicit a cancer promoting genotype. We observed that conditional deletion of Pot1 (protection of telomere), a critical telomere binding protein, in mouse embryo fibroblasts (MEFs) resulted in telomere dysfunction, activation of DNA damage response (DDR), and p53-dependent replicative senescence in vitro. In addition, loss of Pot1 cooperated with p53 deficiency to initiate tumorigenesis in vivo. The objective of this research project is to generate a conditional Pot1 knockout mouse model to: 1) characterize the molecular determinants of Pot1-induced p53-dependent replicative senescence; 2) to determine the biological function of p53 in loss of Pot1 initiated tumorigenesis in vivo; and 3) to cytogenetically characterize chromosomal aberrations in tumor samples, and investigate the function of these aberrations in human tumor initiation and progression. To achieve the objectives, Pot1-deficient mice will be crossed with mice bearing loss of cellular senescence (p21 knockout mouse) or apoptosis components (p53R172P knockin mice) to compare the latency of tumor development and tumor spectrum in mouse cohorts with dysfunctional telomeres. Finally, molecular cytogenetic techniques such as spectral karyotyping (SKY), array-comparative genomic hybridization (aCGH) and lentivirus-based siRNA will be used to identify chromosomal aberrations and validate potential molecular targets involved in tumorigenesis in conditionally deleted Pot1 mouse cohorts. The long-term goal of this study is to identify molecular targets involved in human cancer initiation or/and progression in the setting of telomere dysfunction.
描述(由申请人提供):端粒是覆盖真核染色体末端的核蛋白结构,由终止于3'单链富G突出端的TTAGGG重复序列组成。端粒由一系列复杂的蛋白质结合,这些蛋白质有助于稳定端粒的形成,并在防止DNA损伤检查点激活方面发挥重要作用。最近的证据表明,端粒功能障碍与人类癌症发病率的增加有关。端粒功能障碍导致双着丝粒染色体的产生,其启动断裂-融合-桥(BFB)循环以引发癌症促进基因型。我们观察到,条件性删除Pot 1(端粒的保护),一个关键的端粒结合蛋白,在小鼠胚胎成纤维细胞(MEFs)导致端粒功能障碍,激活DNA损伤反应(DDR),和p53依赖性复制衰老在体外。此外,Pot 1的缺失与p53缺陷协同启动体内肿瘤发生。本研究的目的是建立条件性Pot 1基因敲除小鼠模型,以:1)表征Pot 1诱导的p53依赖性复制衰老的分子决定因素; 2)确定p53在Pot 1缺失引发的体内肿瘤发生中的生物学功能;以及3)对肿瘤样品中的染色体畸变进行细胞遗传学表征,并研究这些畸变在人类肿瘤发生和发展中的功能。为了实现目标,Pot 1缺陷小鼠将与细胞衰老丧失(p21敲除小鼠)或细胞凋亡组分丧失(p53 R172 P敲入小鼠)的小鼠杂交,以比较端粒功能障碍的小鼠队列中肿瘤发展的潜伏期和肿瘤谱。最后,分子细胞遗传学技术,如光谱核型分析(SKY),阵列比较基因组杂交(aCGH)和基于慢病毒的siRNA将被用来确定染色体畸变和验证潜在的分子靶点参与肿瘤发生的条件性缺失的Pot 1小鼠队列。本研究的长期目标是确定参与端粒功能障碍背景下人类癌症起始或/和进展的分子靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YIBIN DENG其他文献
YIBIN DENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YIBIN DENG', 18)}}的其他基金
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
靶向 eIF4A1 依赖性 HK2 翻译轴预防去势抵抗性前列腺癌
- 批准号:
10051412 - 财政年份:2018
- 资助金额:
$ 15.18万 - 项目类别:
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
靶向 eIF4A1 依赖性 HK2 翻译轴预防去势抵抗性前列腺癌
- 批准号:
10307097 - 财政年份:2018
- 资助金额:
$ 15.18万 - 项目类别:
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
靶向 eIF4A1 依赖性 HK2 翻译轴预防去势抵抗性前列腺癌
- 批准号:
10531862 - 财政年份:2018
- 资助金额:
$ 15.18万 - 项目类别:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
端粒脱帽驱动的乳腺肿瘤发生中功能突变体 p53 的获得
- 批准号:
8153821 - 财政年份:2011
- 资助金额:
$ 15.18万 - 项目类别:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
端粒脱帽驱动的乳腺肿瘤发生中功能突变体 p53 的获得
- 批准号:
8539347 - 财政年份:2011
- 资助金额:
$ 15.18万 - 项目类别:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
端粒脱帽驱动的乳腺肿瘤发生中功能突变体 p53 的获得
- 批准号:
8907720 - 财政年份:2011
- 资助金额:
$ 15.18万 - 项目类别:
Prevention of PTEN deletion driven prostate cancer by selenium
硒预防 PTEN 缺失导致的前列腺癌
- 批准号:
8206703 - 财政年份:2010
- 资助金额:
$ 15.18万 - 项目类别:
Prevention of PTEN deletion driven prostate cancer by selenium
硒预防 PTEN 缺失导致的前列腺癌
- 批准号:
8028115 - 财政年份:2010
- 资助金额:
$ 15.18万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant